One-two home victory for TOYOTA GAZOO Racing
Toyota City, Japan, Sep 12, 2022 – (JCN Newswire) – TOYOTA GAZOO Racing achieved a…
Year: 2022
HKTDC Hong Kong Watch & Clock Fair and Salon de TE conclude
HONG KONG, Sep 12, 2022 – (ACN Newswire) – Jointly organised by the Hong Kong…
AVIA Releases OTT Study in Singapore at its First OTT Upfront Showcase Presenting Premium Content at its Best
Singapore, Sep 12, 2022 – (ACN Newswire) – The Asia Video Industry Association (AVIA) has…
Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024
Debt restructuring supports corporate priorities by realigning debt obligations with expected development and commercialization timelines…
Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss From the European Medicine Agency
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which…
J.P. Morgan to Acquire Renovite Technologies, Inc.
Acquisition of cloud-native payments technology firm to modernize infrastructure and create greater flexibility for the…
Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022
TOKYO, Sep 12, 2022 – (JCN Newswire) – Eisai Co., Ltd. announced today results from…
Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines
BANDUNG, INDONESIA, Sep 12, 2022 – (ACN Newswire) – PT Bio Farma, the holding company…
Axiom Exhibiting at SCDM 2022 Annual Conference
TORONTO, Sept. 11, 2022 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), the premier provider of…
Late Breaking Data Presented at ESMO Congress 2022 Demonstrate Potential of RLY-4008 to Transform Treatment Options for Cholangiocarcinoma Patients with FGFR2-Driven Disease
88% overall response rate (15 out of 17) from interim data of pan-FGFR treatment (FGFRi)-naïve FGFR2-fusion…
Public Sector Retirement Educators Launch FERS Planning & Training Platform
Public Sector Retirement Educators has launched an ADA-compliant online platform that provides federal employees, at…
Golden Tax Relief Enters Top 500 Of Inc. 5000’s Fastest Growing Businesses
Ranked No. 410, Golden Tax Relief has entered the top 500 of Inc. 5000’s list…
CENTRESTAGE showcases talent of local designers
HONG KONG, Sep 11, 2022 – (ACN Newswire) – Asia’s leading fashion event CENTRESTAGE draws…
SpringWorks Therapeutics Announces Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2022
– Nirogacestat Treatment Resulted in Rapid, Sustained and Statistically Significant Improvements in Primary and All…
Presents Positive Safety and Efficacy Data from the Completed Phase 1 Dose Escalation Cohort of ICT01 plus Pembrolizumab in the EVICTION Trial at ESMO Congress 2022
Broad antitumor immune responses and demonstration of durable disease control from solid tumor patients who…
Apexigen Presents New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022
-Sotigalimab in combination with neoadjuvant chemoradiation induced higher pathologic complete response rates, an important predictor…
Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
PHILADELPHIA, Sept. 10, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
CENTRESTAGE ELITES unveils latest fashion trends
HONG KONG, Sep 10, 2022 – (ACN Newswire) – Organised by Hong Kong Trade Development…
KBRA Releases Marketplace Consumer Loan Indices for August 2022; Announces Tier 2 Index Constituent Changes
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its marketplace consumer loan indices for August 2022, providing monthly credit…
Exai Bio Presents Data Demonstrating that its Novel RNA-based Liquid Biopsy Platform has Potential for Early Detection and Monitoring of Colorectal Cancer
– Poster presentation at the 2022 Annual Meeting of the European Society of Medical Oncology…